David Geffen School of Medicine at UCLA presents award for excellence in basic science research

Dr. Huda Zoghbi, a Baylor College of Medicine professor whose work holds promise for treating a range of neurological and neuropsychiatric disorders, received an annual award for excellence in biological and biomedical sciences research from theDavid Geffen School of Medicine at UCLA.The medical school ’s dean, Dr. Kelsey Martin, presented Zoghbi with the 2017Switzer Prize during a Feb. 16 ceremony. Zoghbi received a $25,000 honorarium and a statuette.“Her story is a beautiful illustration of the connection between medicine and science, and a lesson in the value of maintaining curiosity and open-mindedness,” Martin said.Zoghbi, who holds faculty appointments at Baylor in pediatrics, molecular and human genetics, neurology, and neuroscience, said she was humbled by the recognition and hopeful that her work inspires a new generation of physician-scientists.Reed Hutchinson/UCLADr. Huda Zoghbi“If you would like to work on something, don’t let anybody tell you otherwise,” Zoghbi said.She delivered her Switzer Prize lecture, “Genetic and Neurophysiological Approaches to Tackle Neurodevelopmental Disorders,” to an audience of about 250 in UCLA’s Neuroscience Research Building auditorium. Zoghbi also met with UCLA research fellows, doctoral candidates and faculty to share insights from her career.After treating patients for years as a pediatrician, she became fascinated with the origins of disease and undertook a three-year fellow...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

Outdoor adventure education programs often feature common elements, such as backcountry settings, small group sizes, and different levels of challenges. A mandatory outdoor experience program (MOEP), offered at a Canadian university for nearly 50  years, i...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Authors: Uysal SP, Sahin M Abstract Tuberous sclerosis complex (TSC) is an autosomal dominant, multisystem disorder that is characterized by cellular and tissue dysplasia in With the advent of genetic and molecular techniques, mutations in TSC1 or TSC2 genes were discovered to be responsible for mTOR overactivation, which is the underlying mechanism of pathogenesis. TSC is a highly heterogenous clinical entity with variable presentations and severity of disease. The brain, heart, skin, eyes, kidneys, and lungs are commonly involved in this syndrome, with the neurologic symptoms comprising a significant source of mo...
Source: Turkish Journal of Medical Sciences - Category: General Medicine Tags: Turk J Med Sci Source Type: research
AbstractTafamidis, a non ‐nonsteroidal anti‐inflammatory benzoxazole derivative, acts as a transthyretin (TTR) stabilizer to slow progression of TTR amyloidosis (ATTR). Tafamidis meglumine, available as 20‐mg capsules, is approved in more than 40 countries worldwide for the treatment of adults with early‐stage sympt omatic ATTR polyneuropathy. This agent, administered as an 80‐mg, once‐daily dose (4 × 20‐mg capsules), is approved in the United States, Japan, Canada, and Brazil for the treatment of hereditary and wild‐type ATTR cardiomyopathy in adults. An alternative single solid oral dosage formulati...
Source: Clinical Pharmacology in Drug Development - Category: Drugs & Pharmacology Authors: Tags: Original Manuscript Source Type: research
Publication date: Available online 29 March 2020Source: Schizophrenia Research: CognitionAuthor(s): Suzanne Ho-wai So, Xiaoqi Sun, Gloria Hoi Kei Chan, Iris Hiu Hung Chan, Chui De Chiu, Sherry Kit Wa Chan, Wai Yin Elisabeth Wong, Patrick Wing-leung Leung, Eric Yu Hai Chen
Source: Schizophrenia Research: Cognition - Category: Psychiatry Source Type: research
CONCLUSIONS: There appears to be persistent but narrowing income-related inequality in dental visits in Canada and across its provinces over time. In addition, it appears that Canadian provinces are becoming more equal in terms of dental services use. PRACTICAL IMPLICATIONS: Narrowing income-related inequality in dental visits in Canada is promising, suggesting a more equal distribution of dental visits. However, unequal use of dental services remains an issue affecting the Canadian population. PMID: 32220345 [PubMed - as supplied by publisher]
Source: Journal of the American Dental Association - Category: Dentistry Tags: J Am Dent Assoc Source Type: research
Publication date: June 2020Source: Research in Autism Spectrum Disorders, Volume 74Author(s): Kyle M. Frost, Kaylin M. Russell, Brooke Ingersoll
Source: Research in Autism Spectrum Disorders - Category: Psychiatry Source Type: research
I hope you enjoy this new post I wrote for Psychology Today. It’s been quite a time staying home with Nat these three weeks!
Source: Susan's Blog - Category: Child Development Authors: Tags: Uncategorized Source Type: blogs
Conclusion:The observed prevalence of 32.1% for IFs of any type underscores the need for a dental practitioner to review the entire DPR when a patient presents for an initial dental examination (or check-up) or for dental hygiene. Only a single IF (a central giant cell granuloma) provoked alarm, as it was initially considered malignant. Similarly, impacted teeth and suspected cysts need careful evaluation upon discovery to determine how they may be optimally managed.
Source: Dental Technology Blog - Category: Dentistry Source Type: news
Albert Sanfeliu1, Karsten Hokamp2, Michael Gill1 and Daniela Tropea1,3*1Neuropsychiatric Genetics, Department of Psychiatry, School of Medicine, Trinity Translational Medicine Institute, St James Hospital, Dublin, Ireland2Department of Genetics, School of Genetics and Microbiology, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland3Department of Psychiatry, School of Medicine, Trinity College Institute for Neuroscience, Trinity College Dublin, Dublin, IrelandRett syndrome is a rare neuropsychiatric disorder with a wide symptomatology including impaired communication and movement, cardio-respiratory abno...
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
Dr. Huda Zoghbi, a Baylor College of Medicine professor whose work holds promise for treating a range of neurological and neuropsychiatric disorders, received an annual award for excellence in biological and biomedical sciences research from theDavid Geffen School of Medicine at UCLA.The medical school ’s dean, Dr. Kelsey Martin, presented Zoghbi with the 2017Switzer Prize during a Feb. 16 ceremony. Zoghbi received a $25,000 honorarium and a statuette.“Her story is a beautiful illustration of the connection between medicine and science, and a lesson in the value of maintaining curiosity and open-mindedness,&rdq...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
More News: Academies | Alzheimer's | Ataxia | Autism | Baylor College of Medicine | Biology | Brain | Canada Health | Children | Cytology | Genetics | Girls | Hospitals | Lessons | Molecular Biology | Neurology | Neuroscience | Pediatrics | Rett Syndrome | Schizophrenia | Science | Training | Universities & Medical Training